Matthew B. Klein - 19 Feb 2025 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: PTCT
Reported as of: 19 Feb 2025
Net transaction value: -$390,457
SEC form: 4
Accepted by SEC: 21 Feb 2025, 17:20:12 UTC
Prior SEC filing: 10 Jan 2025
Next SEC filing: 24 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Avraham S. Adler, Attorney-in-Fact

Key filing fact

Matthew B. Klein filed Form 4 for PTC THERAPEUTICS, INC. (PTCT) on 21 Feb 2025.

Key facts

This page summarizes Matthew B. Klein's Form 4 filing for PTC THERAPEUTICS, INC. (PTCT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 21 Feb 2025, 17:20.

Change

Previous filing in this sequence was filed on 10 Jan 2025.
Current net transaction value: -$390,457.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PTCT transaction

Common Stock

Sale

Transaction value: $195,224
Shares: -3,897
Change %: -1.4%
Price: $50.10
Shares after: 279,933
Date: 19 Feb 2025
Ownership: Direct
Footnotes: F1

PTCT transaction

Common Stock

Sale

Transaction value: $195,233
Shares: -3,895
Change %: -1.4%
Price: $50.12
Shares after: 276,038
Date: 20 Feb 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 17,500 RSUs from a February 15, 2025 grant of 70,000 RSUs.